Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology
- PMID: 17000698
- DOI: 10.1158/1078-0432.CCR-06-0897
Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology
Comment on
-
Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.Clin Cancer Res. 2006 Feb 15;12(4):1245-50. doi: 10.1158/1078-0432.CCR-05-0225. Clin Cancer Res. 2006. PMID: 16489080 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical